Wells Fargo & Company »

Cellectar Biosciences shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $166 60 2.77
2023-09-30 $189 71 2.67
2023-06-30 $117 60 1.95
2022-12-31 $94 55 1.71
2022-09-30 $0 39 0.00